ANDREA MATTELIANO: Open Payments
NPI 1134544604 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,055 in 130 payments from 33 companies in 2025. Trend: 2023 $3,053 · 2024 $746 · 2025 $3,055
Food & beverage: $2,916Education: $139
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $261 |
| Alexion Pharmaceuticals, Inc. | 7 | $244 |
| ABBVIE INC. | 14 | $191 |
| Otsuka America Pharmaceutical, Inc. | 11 | $184 |
| LivaNova USA, Inc. | 5 | $167 |
| Novartis Pharmaceuticals Corporation | 5 | $135 |
| EMD Serono, Inc. | 4 | $133 |
| TG Therapeutics, Inc. | 5 | $131 |
| UCB, Inc. | 5 | $127 |
| Celgene Corporation | 7 | $126 |
Products named: ULTOMIRIS, REXULTI, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, OCTAGAM IMMUNE GLOBULIN (HUMAN), KESIMPTA, BRIUMVI, Rystiggo, ZEPOSIA.
Industry payments across NY — which companies pay providers there.
